{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:22:37Z","timestamp":1791206557103,"version":"4.1.0"},"reference-count":65,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Abnormalities in subcellular localization and interaction between receptors and their signaling molecules occur within the striatum in Parkinson&amp;s disease (PD) and L\u2010DOPA\u2010induced dyskinesia (LID). Synapse\u2010associated proteins (SAPs), for example, PSD\u201095 and SAP97 organize the molecular architecture of synapses and regulate interactions between receptors and downstream\u2010signaling molecules. Here, we show that expression and subcellular distribution of PSD\u201095 and SAP97 are altered in the striatum of unilateral 6\u2010OHDA\u2010lesioned rats following repeated vehicle (a model of PD) or L\u2010DOPA administration (a model of L\u2010DOPA\u2010induced dyskinesia). Furthermore, following dopamine\u2010depletion and development of behavioral deficits in Rotorod performance, indicative of parkinsonism, we observed a dramatic decrease in total striatal levels of PSD\u201095 and SAP97 (to 25.6 \u00b1 9.9% and 19.0 \u00b1 5.0% of control, respectively). The remaining proteins were redistributed from the synapse into vesicular compartments. L\u2010DOPA (6.5mg\/kg twice a day, 21 days) induced a rotational response, which became markedly enhanced with repeated treatment (day 1: \u201215.8\u00b17.3 rotations\n                    <jats:italic>cf<\/jats:italic>\n                    day 21: 758.2\u00b1114.0 rotations). Post L\u2010DOPA treatment, PSD\u201095 and SAP97 levels increased (367.4 \u00b1 43.2% and 159.9 \u00b1 9.5% from control values, respectively), with both being redistributed toward synaptic membranes from vesicular compartments. In situ hybridization showed that changes in total levels of PSD\u201095, but not SAP97, were accompanied by qualitatively similar changes in mRNA. These data highlight the potential role of abnormalities in the subcellular distribution of SAPs in the pathophysiology of a neurological disease.\n                  <\/jats:p>","DOI":"10.1096\/fj.04-1854fje","type":"journal-article","created":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T20:39:09Z","timestamp":1107981549000},"page":"1-25","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Subcellular redistribution of the synapse\u2010associated proteins PSD\u201095 and SAP97 in animal models of Parkinson&amp;s disease and L\u2010DOPA\u2010induced dyskinesia"],"prefix":"10.1096","volume":"19","author":[{"given":"J. E.","family":"Nash","sequence":"first","affiliation":[{"name":"Toronto Western Research Institute Toronto Western Hospital  Toronto Canada"},{"name":"Department of Psychiatry and Behavioral Sciences Stanford University  Palo Alto California"},{"name":"MRC Centre for Synaptic Plasticity Department of Anatomy School of Medical Sciences University of Bristol University Walk  Bristol United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. H.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Toronto Western Research Institute Toronto Western Hospital  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Collingridge","sequence":"additional","affiliation":[{"name":"MRC Centre for Synaptic Plasticity Department of Anatomy School of Medical Sciences University of Bristol University Walk  Bristol United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Garner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Stanford University  Palo Alto California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Brotchie","sequence":"additional","affiliation":[{"name":"Toronto Western Research Institute Toronto Western Hospital  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,4,1]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/35086062"},{"key":"e_1_2_6_3_1","first-page":"355","article-title":"Striatal molecular mechanisms and motor dysfunction in Parkinson&s disease","volume":"86","author":"Chase T. N.","year":"2001","journal-title":"Adv. Neurol."},{"key":"e_1_2_6_4_1","first-page":"51","article-title":"New insights in Parkinson&s disease therapy: can levodopa-induced dyskinesia ever be manageable","volume":"91","author":"Hadj Tahar A.","year":"2003","journal-title":"Adv. Neurol."},{"key":"e_1_2_6_5_1","first-page":"S179","article-title":"Medical treatment of levodopa-induced dyskinesias","volume":"47","author":"Rascol O.","year":"2000","journal-title":"Ann. Neurol."},{"key":"e_1_2_6_6_1","first-page":"S60","article-title":"Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?","volume":"47","author":"Calabresi P.","year":"2000","journal-title":"Ann Neurol"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-1931(00)00026-4"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-1931(00)00027-6"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn1040"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1224-04.2004"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","unstructured":"Brotchie J. M. Lee J. andVenderova K.(2004In press)L-DOPA-induced dyskinesia in Parkinson&s disease.J. Neural Trans.","DOI":"10.1007\/s00702-004-0251-7"},{"key":"e_1_2_6_12_1","first-page":"273","article-title":"Potential nondopaminergic drugs for Parkinson&s disease","volume":"91","author":"Silverdale M. A.","year":"2003","journal-title":"Adv. Neurol."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10256"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1523\/JNEUROSCI.20-20-07782.2000","article-title":"A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson&s disease","volume":"20","author":"Nash J. E.","year":"2000","journal-title":"J. Neurosci."},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson&s disease","volume":"57","author":"Dunah A. W.","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-15-05546.2001"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1523\/JNEUROSCI.15-03-02354.1995","article-title":"Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein","volume":"15","author":"Muller B. M.","year":"1995","journal-title":"J. Neurosci."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(92)90245-9"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81179-4"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(00)01783-9"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.62.1.755"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-20-08902.2002"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1113\/jphysiol.2002.034918","article-title":"PSD-95 regulates NMDA receptors in developing cerebellar granule neurons of the rat","volume":"548","author":"Losi G.","year":"2003","journal-title":"J. Physiol."},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200204081"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-16-07027.2002"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1042\/bst0300464","article-title":"Interaction of G-proteincoupled receptors with synaptic scaffolding proteins","volume":"30","author":"Kreienkamp H. J.","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205164200"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200209127"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1242\/jcs.111.8.1071","article-title":"E-cadherin mediated cell adhesion recruits SAP97 into the cortical cytoskeleton","volume":"111","author":"Reuver S. M.","year":"1998","journal-title":"J. Cell Sci."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-13-05253.2002"},{"issue":"30","key":"e_1_2_6_31_1","first-page":"928","article-title":"Interaction of SAP97 with minus-end-directed actin motor myosin VI. Implications for AMPA receptor trafficking","volume":"277","author":"Wu H.","year":"2002","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)00161-6"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.148.1.147"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00687-1"},{"key":"e_1_2_6_35_1","volume-title":"The rat brain in stereotaxic co-ordinates","author":"Paxinos G.","year":"1998"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2003.09.001"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)00185-4"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00256.x"},{"key":"e_1_2_6_40_1","volume-title":"HPLC of Macromolecules: A Practical Approach","author":"Marsden C. A.","year":"1989"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(70)90187-3"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0270(03)00049-9"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90796-X"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6819"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.2002.0499"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01843.x"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2004.01.007"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2004.07.005"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10312"},{"key":"e_1_2_6_50_1","unstructured":"Johnston T. H. Lee J. Gomez-Rimirez J. Fox S. H. andBrotchie J. M.A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson&s disease.Exp. Neurol.(In press)"},{"key":"e_1_2_6_51_1","first-page":"53","article-title":"Characterization of a rodent model in which to investigate the molecular and cellular mechanisms underlying the pathophysiology of L-dopa-induced dyskinesia","volume":"78","author":"Henry B.","year":"1998","journal-title":"Adv. Neurol."},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6771"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1999.82.6.3575"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00924-3"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01121-X"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(90)90112-N"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1987.tb04106.x"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.31.19518"},{"issue":"21","key":"e_1_2_6_59_1","first-page":"105","article-title":"A novel multiple PDZ domain-containing molecule interacting with N-methyl-D-aspartate receptors and neuronal cell adhesion proteins","volume":"273","author":"Hirao K.","year":"1998","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6996"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4886(03)00064-5"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)00013-1"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91686-7"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-12-04732.1998"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00227776"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-16-06105.2001"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-1854fje","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.04-1854fje","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-1854fje","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:33:54Z","timestamp":1786390434000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.04-1854fje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1096\/fj.04-1854fje"],"URL":"https:\/\/doi.org\/10.1096\/fj.04-1854fje","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"2004-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}